Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JMP Genomics
    Registered Vendor
    • Aug 2009
    • 3

    #1

    Next-Gen Biomarker Discovery Using JMP® Genomics

    ===============================================
    Next-Gen Biomarker Discovery Using JMP® Genomics
    ===============================================

    Oct. 6 Rockville, MD
    Oct. 7 Bedminster, NJ
    Oct. 8 Broad Institute, Cambridge, MA

    Register at: http://www.jmp.com/about/events/seminars/

    Join representatives of the National Center for Genome Resources (NCGR) and SAS at the prestigious Broad Institute to learn how NCGR scientists have integrated JMP Genomics into their standard workflows for next-generation Illumina sequence analysis.

    At this complimentary seminar, Faye Schilkey of the National Center for Genome Resources will discuss cutting-edge NCGR research projects that display the flexibility and power of next-generation sequencing technology, and share how NCGR is tackling data storage and analysis challenges by pairing its Alpheus for data management and analysis solution with JMP Genomics for dynamic data analysis. Doug Robinson, PhD, Application Scientist Manager for JMP Genomics will join Schilkey to:

    • Show how Illumina technology platforms can be used to generate high-quality genomics data for statistical and functional analysis with JMP Genomics.
    • Discuss how JMP Genomics can generate high-quality; significant gene lists for downstream biological exploration.

    Register for these and other JMP seminars at http://www.jmp.com/about/events/seminars/
    Last edited by JMP Genomics; 09-11-2009, 12:40 PM.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...